Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Everbright Cell Medical Biotech is a clinical-stage biotechnology company based in China that specializes in the development of advanced cell therapies and regenerative medicine products. The company focuses on leveraging mesenchymal stem cells (MSCs), natural killer (NK) cells, and exosome-based technologies to treat a variety of conditions, including osteoarthritis, autoimmune disorders, and solid tumors. Everbright Cell Medical operates integrated research, development, and manufacturing facilities designed to meet international GMP standards. Their pipeline includes several candidates in clinical trials, aiming to provide innovative solutions for unmet medical needs in the fields of orthopedics and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Everbright Cell Medical Biotech.